financetom
Business
financetom
/
Business
/
Market Chatter: Veon's Kyivstar Targets to Raise up to $200 Million in US Listing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Veon's Kyivstar Targets to Raise up to $200 Million in US Listing
Aug 11, 2025 5:23 AM

07:56 AM EDT, 08/11/2025 (MT Newswires) -- Veon's (VEON) Kyivstar subsidiary plans to raise between $50 million and $200 million through a Nasdaq listing this year following its planned merger with special purpose acquisition company Cohen Circle Acquisition (CCIR), Reuters reported Monday, citing three sources familiar with the matter.

Veon and Cohen Circle earlier said they have secured about $52 million in non-redemption agreements with institutional investors, meeting the minimum cash condition for the merger, which is expected to be completed in Q3.

Shareholders are scheduled to vote on the deal on Tuesday.

Veon, Cohen Circle and Kyivstar did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing
Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing
Oct 23, 2024
03:19 AM EDT, 10/23/2024 (MT Newswires) -- David Zaccardelli, Director, President and Chief Executive Officer, on October 18, 2024, sold 514,152 shares in Verona Pharma ( VRNA ) for $2,253,237. Following the Form 4 filing with the SEC, Zaccardelli has control over a total of 14,736,552 shares of the company, with 14,736,552 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1657312/000110465924110659/xslF345X05/tm2426639-2_4seq1.xml Price: 34.97,...
L'Oreal shares fall after its Q3 sales miss forecasts
L'Oreal shares fall after its Q3 sales miss forecasts
Oct 23, 2024
PARIS (Reuters) - L'Oreal's shares slid lower on Wednesday after third quarter sales figures from the French cosmetics giant missed expectations, as low consumer confidence in China sapped demand for beauty products. L'Oreal shares were down around 3 percent in early session trading. Late on Tuesday, L'Oreal posted sales for the three months to the end of September of 10.28...
Oct 23, 2024
...
Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing
Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing
Oct 23, 2024
03:17 AM EDT, 10/23/2024 (MT Newswires) -- Mark W Hahn, Chief Financial Officer, on October 18, 2024, sold 525,768 shares in Verona Pharma ( VRNA ) for $2,303,773. Following the Form 4 filing with the SEC, Hahn has control over a total of 13,813,920 shares of the company, with 13,813,920 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1657312/000110465924110658/xslF345X05/tm2426639-1_4seq1.xml Price: 34.97, Change: +0.10,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved